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Abstract. Alcohol consumption has been recognized as a risk 
factor for breast cancer. Experimental studies demonstrate 
that alcohol exposure promotes the progression of existing 
mammary tumors. However, the mechanisms underlying this 
effect remain unclear. In the present study, the role of vascular 
endothelial growth factor (VEGF) in alcohol promotion of 
breast cancer development was investigated using a mouse 
xenograft model of mammary tumors and a three-dimensional 
(3D) tumor/endothelial cell co-culture system. For the mouse 
xenograft model, mouse E0771 breast cancer cells were 
implanted into the mammary fat pad of C57BL6 mice. These 
mice were exposed to alcohol in their drinking water. For 
the 3D co-culture system, E0771 cells and MDA-MB231 
breast cancer cells were co-cultured with SVEC4-10EE2 
and human umbilical vein endothelial cells, respectively. The 
results demonstrated that alcohol increased tumor angiogen-
esis and accelerated tumor growth. Furthermore, it appeared 
that alcohol induced VEGF expression in breast cancer cells 
in vitro and in vivo. Blocking VEGF signaling by SU5416 
inhibited tumor angiogenesis in the 3D tumor/endothelial cell 
co-culture system. Furthermore, injection of SU5416 into mice 
inhibited alcohol-promoted mammary tumor growth in vivo. 
These results indicate that alcohol may promote mammary 
tumor growth by stimulating VEGF-dependent angiogenesis. 
Introduction
Breast cancer is the most common malignant tumor in females 
worldwide and is the second leading cause of cancer-related 
mortality in the USA (1,2). There are multiple risk factors 
for breast cancer, including genetic, reproductive/hormonal, 
environmental and other lifestyle factors (3). Epidemiological 
studies indicate that alcohol consumption increases the risk 
of breast cancer in a dose-dependent manner (4-9). In addi-
tion, alcohol enhances the growth of existing breast tumors 
and promotes metastasis (10-12). However, the mechanisms 
underlying these effects remain unclear. 
Tumor growth and metastasis are dependent on angio-
genesis. Vascular endothelial growth factor (VEGF) is one 
of the most important known factors which stimulates vascu-
logenesis and angiogenesis. VEGF has an important role in 
tumor angiogenesis via promoting proliferation, migration, 
stabilization and survival of endothelial cells as well as tumor 
cells (13,14). It has been demonstrated that the VEGF expres-
sion in breast cancer tissues is significantly higher than that in 
the adjacent normal tissues (15). We previously demonstrated 
that alcohol promoted angiogenesis and induced the expres-
sion of monocyte chemotactic protein-1 (MCP-1). However, 
MCP-1 only partially mediated the effect of alcohol, that is, 
blocking MCP-1 signaling only partially reversed the effect 
of alcohol on angiogenesis and mammary tumor growth (16). 
Alcohol-induced tumor promotion may be mediated by 
multiple factors and signaling pathways. Considering the 
important role of VEGF in tumor angiogenesis and progres-
sion, we hypothesized that VEGF signaling is involved in 
alcohol promotion of tumor angiogenesis and mammary 
tumor growth. In the present study, we utilized in vitro and 
in vivo model systems to address this hypothesis.
Materials and methods
Materials. Ethanol, fibrinogen, aprotinin and thrombin were 
purchased from Sigma-Aldrich (St. Louis, MO, USA), and 
SU5416 was purchased from Calbiochem (San Diego, CA, 
USA). Rat anti-mouse CD31 monoclonal antibody was obtained 
from BD Biosciences (San Diego, CA, US), while anti-VEGF 
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antibody was obtained from Santa Cruz Biotechnology, Inc. 
(Dallas, TX, USA). Cytodex 3 beads were obtained from 
Amersham Pharmacia Biotech Inc. (Piscataway, NJ, USA). 
Cell culture. Mouse mammary adenocarcinoma cell line 
(E0771) was provided by Dr. Enrico Mihich (Roswell Park 
Cancer Institute, Buffalo, NY, USA) and maintained in 
DMEM (Gibco-BRL, Carlsbad, CA, USA) supplemented 
with 10% fetal bovine serum (FBS; Hyclone, Logan, 
UT, USA), penicillin (100 U/ml;), streptomycin (100 
U/ml) and amphotericin B (0.25 mg/ml) at 37˚C with 5% CO2 
(GBCBIO™ Technologies, Guangzhou, China). MDA-MB231 
breast cancer cells and SVEC4-10EE2 murine endothelial 
cells (both American Type Culture Collection, Manassas, 
VA, USA) were grown in DMEM medium containing 10% 
FBS and 100 U/ml penicillin and streptomycin at 37˚C with 
5% CO2. Human umbilical vein endothelial cells (HUVECs; 
American Type Culture Collection) were isolated from fresh 
human placentas with type I collagenase (1 mg/ml) and grown 
in Clonetics Endothelial Cell Growth Medium-2 (EGM-2; 
Lonza, Walkersville, MD, USA). HUVECs were used between 
passages 3 and 10. 
Animals and alcohol exposure. Female C57BL/6 mice 
(5-6 weeks old) were purchased from the Experimental 
Animal Center of Anhui Province (Hefei, China). All proce-
dures were conducted according to the Guidelines of the 
Animal Welfare Act approved by the Institutional Animal 
Care and Use Committee of the Anhui Medical University 
(Hefei, China). The mice were placed on a standard chow 
diet and were allowed to acclimatize for one week prior to 
starting the study. The paradigm of alcohol exposure has 
been previously described (16). Briefly, mice were divided 
into two groups and fed with standard chow ad libitum. 
In the control group, the mice were provided with regular 
drinking water (n=20). In the alcohol-exposed group (n=18), 
the mice received repeated cycles of chronic intermit-
tent ethanol (2% v/v) exposure (12 h/day, 8:00pm-8:00am) 
for three weeks. The consumption of regular water or 
alcohol-containing water in the two groups was monitored 
daily and no significant difference in the liquid intake 
between the control and ethanol group was identified. The 
average consumption of water or ethanol-containing water 
for each mouse was ~4 ml/day. The study was approved by 
the ethics committee of Anhui Medical University.
Mouse tumor xenograft model. E0771 mouse breast cancer 
cells are syngeneic to C57BL/6 mice. E0771 cells, implanted 
subcutaneously in C57BL/6 mice, are immunosuppressive 
and highly aggressive, invading locally into dermal layers 
and the peritoneum as well as distantly to the lung, and have 
characteristics which reflect the human disease (16,17). These 
cells have been extensively used for mouse tumor xenograft 
models. Briefly, three days following alcohol exposure, E0771 
cells [2.5x105 in 100 µl phosphate-buffered saline (PBS)] 
were injected into the secondary mammary fat pad of mice 
using a 23-gauge needle. Following implantation, the mice 
were continually provided normal drinking water or water 
containing 2% ethanol. The tumor size was monitored every 
three days. Two perpendicular dimensions of tumors were 
measured using a dial caliper and the tumor volume was 
calculated based on the formula: V=0.24a x b2 (a, the longest 
dimension and b, the shortest dimension). Following implanta-
tion, 24 days later the mice were sacrificed and the tumors 
were harvested for further detection (16). 
To investigate the role of VEGF in alcohol-induced 
tumor promotion, an inhibitor of the VEGF receptor, Z-3-[(2, 
4-dimethylpyrrol-5-yl) methylidenyl]-2-indolinone (SU5416; 
Sigma-Aldrich) was injected into the mice. One day following 
alcohol exposure, animals received intraperitoneal injection of 
SU5416 [10 mg/kg in 100 µl, Su5416 was dissolved in ethanol and 
diluted in 5% Tween-80 (Amresco LLC, Solon, OH, USA) and 
5% PEG-400 (Shandong Lunan Chemical Technology Co., Ltd, 
Tengzhou City, China) prior to injection] every three days. The 
dosage has been previously demonstrated to effectively inhibit 
VEGF signaling in mice (18). The tumor size was monitored 
every three days. 
Immunohistochemistry (IHC) and evaluation of average 
microvessel density (AMVD). The procedure for immu-
nohistochemical analysis was performed as described 
previously (19). Tumor tissues were sectioned at the thickness 
of 4 µm. The sections were incubated in methanol (0.3% H2O2) 
for 30 min and treated with 0.1% Triton X-100 (Amresco LLC) 
for 10 min. The sections were washed with PBS three times 
and blocked with 1% bovine serum albumin (BSA; Amresco 
LLC) and 0.01% Triton X-100 for 1 h at room temperature. 
The sections were incubated with anti-VEGF antibody (1:100) 
or anti‑CD31 (1:50) antibody overnight at 4˚C. Negative 
controls were performed by staining with isotype-matched 
IgG or PBS. Following rinsing in PBS, the sections were incu-
bated with goat anti-rat biotinylated monoclonal secondary 
antibodies (Vector Laboratories Inc., Burlingame, CA, USA) 
for 1 h at room temperature. The sections were washed three 
times with PBS, then incubated in avidin-biotin-peroxidase 
complex (1:100 in PBS; Vector Laboratories Inc., Burlingame, 
CA, USA) for 1 h and developed in 0.05% 3,3'-diaminoben-
zidine (Sigma-Aldrich) containing 0.003% H2O2 in PBS. The 
tumor microvessels that were visualized by CD31 IHC were 
examined under a microscope (Olympus CX31; Olympus 
Corporation, Tokyo, Japan). Ten random fields were quantified 
and the AMVD was expressed as the number of microves-
sels/mm2 area.
Three‑dimensional (3D) endothelial tumor cell co‑culture 
system. To investigate the effect of alcohol on tumor 
angiogenesis, a 3D tumor/endothelial cell co-culture was 
performed as described previously (16,20). In this model, 
endothelial cells were cultured on a fibrin gel bead system 
alone or with tumor cells to form a 3D capillary tube-like 
network. Briefly, HUVECs or SVEC4 cells were trypsinized 
and the cells (1x106) were mixed with cytodex beads (3x103) 
in a 4 ml medium (EGM-2 for HUVECs and DMEM for 
SVECs). The mixtures were incubated at 5% CO2 at 37˚C 
and gently shaken every 20 min for 4 h. Following this, 4 ml 
of fresh medium was added to the tubes and the incubation 
continued for another 4 h. The mixtures of cells/cytodex beads 
were transferred to 25 ml tissue culture flasks and incubated 
overnight to allow the bead-non-attached cells to adhere to 
the flask. Following incubation, the mixtures of cells/cytodex 
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beads were transferred to a 50 ml centrifuge tube and washed 
three times with 20 ml of Ca2+- and Mg2+-free PBS. Then, 
the beads with adherent cells were resuspended in medium 
[2.5 mg/ml fibrinogen, 0.15 U/ml aprotinin (Amresco LLC), 
pH 7.4]. Following this, 0.5 ml of the fibrinogen/bead suspen-
sion was added to 24-well cell culture plates which were 
pre-coated with 0.625 U of thrombin (Sigma-Aldrich). The 
fibrinogen/bead solution was allowed to coagulate for 5 min 
at room temperature and was then cultured in 5% CO2 at 
37˚C for 20 min. The resulting fibrin gels contained endo-
thelial cells (HUVECs or SVECs) adhering to the beads. 
Then, 1 ml of medium (0.15 U/ml aprotinin) was added to 
each well to equilibrate with the fibrin clot for 30 min at 37˚C 
and 5% CO2. The medium was removed and replaced with 
1 ml of fresh medium (0.15 U/ml aprotinin). For co-culture of 
endothelial cells/breast tumor cells, E0771 or MDA-MB231 
breast cancer cells (2x104 or 4x104, respectively) were layered 
on top of the fibrin gels. The medium was changed every day.
In vitro alcohol exposure. A method utilizing sealed 
containers was used to maintain alcohol concentrations in 
the cell culture system (21). Briefly, the appropriate amount 
of ethanol (using 95% ethanol stock) was added to the culture 
medium to reach the desired concentration (0.2%). The cell 
culture plates were placed in a sealed plastic container. In 
each container, a water bath with 200 ml 0.2% ethanol was 
deposited in order to maintain the ethanol concentration. 
Prior to sealing each container, CO2 (60 ml) was injected. 
The containers were placed in a humidified environment and 
maintained at 37˚C with 5% CO2. With this method, ethanol 
concentrations were maintained constantly over time in a cell 
culture medium (21). 
Immunoblotting. The immunoblotting was performed as 
previously described (22). Briefly, aliquots of the protein 
samples (30 µg) were separated on an SDS-polyacrylamide 
gel (Sigma-Aldrich) and were transferred to nitrocellulose 
membranes. The membranes were blocked with 5% BSA solu-
tion [pH 7.4, 0.05% Tween-20 (Amresco LLC) in PBS] for 1 h 
at room temperature. Anti-VEGF antibody (1:500) was added 
to the membranes (Millipore, Billerica, MA, USA) for 1 h at 
room temperature. Membranes were probed with goat anti-rat 
monoclonal horseradish peroxidase-conjugated secondary 
antibody (Amersham Life Science, Arlington Heights, IL, 
USA). The signals were detected by using the enhanced chemi-
luminescence method (Amersham Life Sciences) and were 
exposed to X‑ray film for autoradiography. The membranes 
were stripped with a stripping buffer for 15 min at room 
temperature and immunoblotted with a rabbit anti-mouse actin 
monoclonal antibody (Santa Cruz Biotechnology, Inc.). The 
images were scanned and the signal intensity was quantified 
with Image J software (NIH, Bethesda, MD, USA).
VEGF enzyme‑linked immunosorbent assay (ELISA). ELISA 
was performed in 100-µl volumes in triplicate using commer-
cial kits for VEGF, according to the manufacturer's instructions 
(R&D Systems, Minneapolis, MN, USA). The plates were 
read at 450 nm on an ELx800 absorbance microplate reader 
(Bio-Tek Instruments Inc., Winooski, VT, USA).
Statistical analysis. The data were analyzed using SPSS 17.0 
software (SPSS, Inc., Chicago, IL, USA). All data are repre-
sented as the mean ± SEM. Differences among the treatment 
groups were examined using analysis of variance. In the cases 
where significant differences were detected, specific post‑hoc 
comparisons between the treatment groups were examined 
with Student-Newman-Keuls tests. In a number of the experi-
ments, the results were analyzed by an unpaired Student's 
t‑test. P<0.05 was considered to indicate a statistically signifi-
cant difference. 
Results
Ethanol induces VEGF expression and tumor angiogenesis. 
The effect of alcohol on VEGF expression and tumor angiogen-
esis was investigated in a mouse xenograft model of mammary 
tumors. As demonstrated in Fig. 1A, the VEGF immunore-
activity in the mammary tumor tissues of mice exposed to 
alcohol was higher than that of the control mice. The AMVD 
was also examined using CD31 (a marker of endothelial cells) 
IHC. The quantification data are presented in Fig. 1B. Alcohol 
consumption significantly increased the AMVD in mammary 
tissues. To confirm alcohol stimulation of VEGF expression, 
we examined the effect of alcohol on E0771 mouse breast 
cancer cells in culture. Alcohol exposure upregulated VEGF 
Figure 1. Effect of alcohol exposure on VEGF expression and angiogenesis in mice. (A) E0771 mouse breast cancer cells were implanted in mammary fat pads 
of C57BL6 mice. The mice were exposed to alcohol in drinking water for two weeks. Mice were sacrificed and mammary tumors were dissected and sectioned 
for VEGF IHC as described in Materials and methods. (B) Tumor microvessels were identified by CD31 IHC and the AMVD was quantified and expressed as 
the number of microvessels/mm2 area. The results are represented as the mean ± SEM of 20-22 animals. *Denotes a statistically significant difference (P<0.05). 
VEGF, vascular endothelial growth factor; IHC, immunohistochemistry; AMVD, average microvessel density.
 A  B
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expression in E0771 cells (Fig. 2A) and increased the secretion 
of VEGF to the culture medium (Fig. 2B). 
Ethanol promotes tumor angiogenesis. We hypothesized that 
alcohol increased VEGF production in breast cancer cells 
and stimulated angiogenesis of endothelial cells. A previously 
described 3D angiogenic model was utilized to test this hypoth-
esis. With this system, we previously demonstrated that breast 
cancer cells (E0771 cells or MDA‑MB231 cells) significantly 
increased the vascular sprout formation of endothelial cells 
(SVECs or HUVECs) (16). In the present study, VEGF signaling 
in tumor/endothelial cell co-culture was blocked using SU5416, 
an inhibitor of VEGF receptor 2 (VEGFR2). As demonstrated in 
Fig. 3A, inclusion of breast cancer cells (E0771 or MDA-MB231) 
in this 3D co-culture system increased endothelial cell sprouting, 
 B A
Figure 2. Effect of alcohol on VEGF expression in E0771 cells. (A) E0771 cells were exposed to alcohol (0 or 0.2%) for the indicated times and cell lysates 
were collected. The expression of VEGF was determined by western blotting as described in Materials and methods. The experiment was replicated three 
times. (B) E0771 cells were exposed to alcohol (0 or 0.2%) for 12 or 24 h. The CM was collected for the analysis of VEGF by enzyme-linked immunosorbent 
assay. The experiment was replicated three times. *Denotes a statistically significant difference (P<0.05). VEGF, vascular endothelial growth factor; CM, 
conditioned medium; EtOH, ethanol.
Figure 3. Effect of alcohol on tumor angiogenesis in vitro. (A) The 3D tumor/endothelial cell co-culture system was set up as described in Materials and 
methods. Endothelial cells (SVECs or HUVECs) attached to cytodex beads were suspended in the fibrin gel containing SU5416 (0 or 2 µM) and breast cancer 
cells (E0771 or MDA-MB231) were placed on top of the gel. The endothelial cell sprouting was examined and recoded under a microscope following 12 h 
in culture. The percentage of beads with endothelial sprouts was calculated. EC, SVECs or HUVECs; TC, E0771 or MDA-MB231 cells. (B) SVEC/E0771 
cell co-culture with/without SU5416 (2 µM) was exposed to alcohol (0 or 0.2%) for 12 h. Following this, the percentage of beads with endothelial sprouts was 
quantified. The experiment was replicated three times. (C) E0771 cells were maintained in a medium containing 1% FBS and exposed to alcohol (0 or 0.2%) 
for 24 h. The CM was collected and SVECs were incubated with this CM for 12 h. Then, the percentage of beads with endothelial sprouts was calculated. 
(D) The CM was collected from alcohol (0 or 0.2%)-treated E0771 cells and SU5416 (0 or 2 µM) was added to the medium. SVECs were then incubated with 
this conditioned medium for 12 h. The experiments were replicated three times. Each data point represents the mean ± SEM of three replicates.*P<0.05 and 
**P<0.01. 3D, 3-dimensional; EC, endothelial cells; TC, tumor cells; CM, conditioned medium; EtOH, ethanol.
 A  B  C
 D
Figure 4. Effect of alcohol on mammary tumor growth in vivo. The implantation 
of E0771 cells in C57Bl6 mice and alcohol exposure was performed as described 
in Materials and methods. One day following E0771 cell implantation, mice 
received an intraperitoneal injection of SU5416 (0 or 10 mg/kg) every three days. 
The size of the mammary tumor was measured every three days as described in 
Materials and methods (n=12 for each treatment group). EtOH, ethanol.
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which was indicative of enhanced angiogenesis. Treatment with 
SU5416 completely blocked the promotion of angiogenesis 
mediated by breast cancer cells. Alcohol exposure did not 
increase endothelial cell sprouting when the endothelial cells 
were cultured alone; however, it significantly increased endo-
thelial cell sprouting in SVEC/E0771 co-culture (Fig. 3B). More 
importantly, SU5416 blocked alcohol-stimulated angiogenesis 
(Fig. 3B). To confirm the role of VEGF in alcohol‑stimulated 
angiogenesis, the effect of conditioned medium collected from 
alcohol-treated E0771 cells on angiogenesis was examined. 
As demonstrated in Fig. 3C, E0771 cell-conditioned medium 
significantly increased endothelial cell sprouting and alcohol 
exposure further enhanced this effect. SU5416 completely 
blocked alcohol-stimulated angiogenesis. These results 
suggested that alcohol-enhanced tumor angiogenesis was medi-
ated by VEGF signaling. 
SU5416 inhibits ethanol‑promoted tumor growth in mouse 
tumor xenograft model. A well-established mouse xenograft 
model of mammary tumors was utilized to validate the role of 
VEGF in alcohol-induced tumor promotion in vivo. As demon-
strated in Fig. 4, alcohol consumption significantly promoted 
the growth of mammary tumors in C57BL6 mice. Injection 
of SU5416 inhibited alcohol-stimulated tumor growth. These 
results suggested that alcohol promotion of tumor growth may 
be mediated by VEGF-dependent angiogenesis.
Discussion
Alcohol consumption promotes the growth and metastasis of 
breast cancer (10-12). However, the mechanisms underlying this 
effect remain unclear. VEGF has been implicated in tumor angio-
genesis and progression. In the present study, it was demonstrated 
that alcohol increases tumor angiogenesis and accelerates tumor 
growth. Alcohol upregulates VEGF expression in breast cancer 
cells in vitro and in vivo. Blocking VEGF signaling inhibits 
alcohol-stimulated tumor angiogenesis in a 3D tumor/endothelial 
cell co-culture system. Furthermore, blocking VEGF signaling 
inhibited alcohol-accelerated mammary tumor growth in mice. 
These results suggest that VEGF-dependent angiogenesis has an 
important role in alcohol-mediated tumor promotion. 
Consistent with epidemiological evidence, alcohol 
exposure promotes tumor progression and malignancy in 
animals (16,23,24,25). In the present study, it was demon-
strated that alcohol at a moderate concentration (2% in 
drinking water during the dark cycle) enhances mammary 
tumor growth in C57BL6 mice. Our previous results and 
studies by others suggested that alcohol exposure may 
enhance angiogenesis (16,23,26,27). The mechanisms under-
lying alcohol-stimulated angiogenesis, however, are complex 
and unclear. Alcohol may directly target endothelial cells, 
or regulate the interaction between endothelial and tumor 
cells. To the best of our knowledge, our previous study was 
the first to demonstrate that alcohol promotes tumor/endo-
thelial cell interaction and enhances tumor angiogenesis in a 
3D co-culture of tumor/endothelial cells (16). In this earlier 
study, we demonstrated that alcohol stimulated MCP-1 
secretion from mammary tumor cells, which enhanced endo-
thelial angiogenesis. However, blocking MCP-1 signaling only 
partially reversed the effect of alcohol on tumor angiogenesis. 
Therefore, we hypothesized that other factors are responsible 
for mediating alcohol-stimulated angiogenesis. 
VEGF is one of the most potent effectors of physiological 
and pathological angiogenesis, which has been proved to be 
an important factor for tumor occurrence, progression and 
metastasis of breast cancer (13). In the tumor microenviron-
ment, VEGF is derived from various sources, including tumor 
cells, inflammatory and stromal cells, platelets and vascular 
cells (28). VEGF regulates multiple aspects of tumor angio-
genesis through two high‑affinity receptor tyrosine kinases, 
VEGFR1 (Flt-1) and VEGFR2/KDR (Flk-1), on endothelial 
cells. The binding of VEGF and VEGFR results in endothelial 
cell proliferation, migration, differentiation, tube formation and 
upregulation of vascular permeability (29). Furthermore, VEGF 
has been reported to be an indirect leukocyte migrating factor 
through inducing the expression of MCP-1 and IL-8 (30,31). In 
the present study, it was demonstrated that SU5416, a tyrosine 
kinase inhibitor of VEGFR2, not only blocks tumor cell-stim-
ulated angiogenesis but also eliminates alcohol-mediated 
promotion of tumor angiogenesis (Fig. 3). Furthermore, SU5416 
significantly inhibits alcohol-stimulated mammary tumor 
growth in mice. Therefore, this study confirms that VEGF has 
an important role in alcohol promotion of mammary tumor 
progression. Furthermore, it appears that the role of VEGF in 
alcohol‑mediated tumor promotion is not tumor type‑specific. It 
has been reported that moderate alcohol consumption increases 
the expression of VEGF and angiogenesis in a mouse xenograft 
model of melanoma (16). Multiple factors and signaling path-
ways may be responsible for alcohol promotion of mammary 
tumor progression and VEGF signaling appears to be an impor-
tant one. Future studies are required to elucidate the underlying 
mechanisms whereby alcohol regulates the expression of VEGF. 
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